The mission of the American Academy of Ophthalmology is to protect sight and empower lives by serving as an advocate for patients and the public, leading ophthalmic education, and advancing the profession of ophthalmology.
Join us for our annual alumni reception at the AAO annual meeting in Chicago on Sunday, October 2nd.
Optical coherence tomographic angiography (OCTA) is the most important new clinical OCT technology in the past decade. It became available as a clinical instrument in 2014. Since then it has been applied to a wide range of retinal and optic nerve diseases. This presentation will review the current state of the art and key clinical applications. I will also report on the development of several novel OCT technologies in our laboratory that may have important clinical applications in the near future.
The European Association for Vision and Eye Research (EVER) congress is a site for clinicians and scientists to discuss their latest advances, and to encourage the participation of young ophthalmologists and visual scientists, as they are undoubtedly the future of our society. Sharing knowledge is usually the main purpose of the Congress, but this year we also need to re-launch the society encouraging the participation of students, residents in training and young investigators.
In a time of technological disruption and evolution, when even things as familiar as vision, computers and automobiles seem to be on the edge of amazing reinvention, FiO LS brings forward true visionaries to speak about discoveries soon to come.
The Fall Vision Meeting is a small, high quality, international meeting sponsored by Optica for researchers in visual neuroscience, optics and psychophysics. The small and focused nature of the meeting and its single-track format foster active discussion and often forge friendships and collaborations.
This annual symposium continues to be held in partnership between SPIE and COS—Chinese Optical Society, providing an international showcase for the latest research in biomedical optics, advanced optical imaging, quantum and nonlinear optics, laser processing, plasmonics, holography, and more.
Our mission is to reduce worldwide visual disability and blindness by promoting the education and professional interaction of vitreoretinal specialists, providing optimal care for patients with vitreoretinal diseases, and encouraging, through clinical and basic research, the discovery and development of new means to further patient care.
